These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14711357)

  • 1. Francisella: a little bug hits the big time.
    Elkins KL; Cowley SC; Collazo CM
    Expert Rev Vaccines; 2003 Dec; 2(6):735-8. PubMed ID: 14711357
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious diseases. An obscure weapon of the cold war edges into the limelight.
    Vogel G
    Science; 2003 Oct; 302(5643):222-3. PubMed ID: 14551418
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the O-antigen of Francisella tularensis subspecies tularensis strain OSU 10.
    Thirumalapura NR; Goad DW; Mort A; Morton RJ; Clarke J; Malayer J
    J Med Microbiol; 2005 Jul; 54(Pt 7):693-695. PubMed ID: 15947437
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines against Francisella tularensis.
    Wayne Conlan J; Oyston PC
    Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology and prevention of tularemia].
    Srebnitskaia IV; Kas'ianenko TI
    Feldsher Akush; 1987 Feb; 52(2):12-6. PubMed ID: 3646961
    [No Abstract]   [Full Text] [Related]  

  • 8. Francisella virulence: significant advances, ongoing challenges and unmet needs.
    Oyston PC; Griffiths R
    Expert Rev Vaccines; 2009 Nov; 8(11):1575-85. PubMed ID: 19863250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of a mechanism of oxidative stress regulation in Francisella tularensis live vaccine strain.
    Ma Z; Russo VC; Rabadi SM; Jen Y; Catlett SV; Bakshi CS; Malik M
    Mol Microbiol; 2016 Sep; 101(5):856-78. PubMed ID: 27205902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
    Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
    Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
    Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Francisella tularensis persistence in the body of highly sensitive animals].
    Shlygina KN
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):110-2. PubMed ID: 8701641
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress, challenges, and opportunities in Francisella vaccine development.
    Elkins KL; Kurtz SL; De Pascalis R
    Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subpopulations of Francisella tularensis ssp. tularensis and holarctica: identification and associated epidemiology.
    Petersen JM; Molins CR
    Future Microbiol; 2010 Apr; 5(4):649-61. PubMed ID: 20353304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against Francisella tularensis--past, present and future.
    Conlan JW
    Expert Rev Vaccines; 2004 Jun; 3(3):307-14. PubMed ID: 15176947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.